Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

WOMEN ORGANIZED TO RESPOND TO LIFE THREATENING DISEASES

UEI: FLKRW3PA2FK5CAGE: 45GU4

WOMEN ORGANIZED TO RESPOND TO LIFE THREATENING DISEASES is a federal contractor, registered under UEI FLKRW3PA2FK5 and CAGE code 45GU4. It has been awarded $2,576,590 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services, Department Of Health And Human Services (hhs), and Federal Communications Commission.

Contact Information

Registration and classification details

Registration

UEI Code

FLKRW3PA2FK5

CAGE Code

45GU4

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit OrganizationWoman-Owned BusinessMinority-Owned BusinessBlack American OwnedDOT Certified DBE

NAICS Codes

624190Other Individual and Family Services(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

WOMEN ORGANIZED TO RESPOND TO LIFE THREATENING DISEASES specializes in community-based public health outreach, disease prevention programming, and health equity initiatives targeting underserved populations. Their core capabilities include designing and implementing culturally competent health educa...

WOMEN ORGANIZED TO RESPOND TO LIFE THREATENING DISEASES specializes in community-based public health outreach, disease prevention programming, and health equity initiatives targeting underserved populations. Their core capabilities include designing and implementing culturally competent health education campaigns, coordinating mobile health services, and facilitating access to preventive care for populations affected by HIV/AIDS, hepatitis, and other life-threatening conditions. The organization leverages deep community engagement strategies, trauma-informed care frameworks, and data-driven intervention models to improve health outcomes in high-risk urban environments. Key differentiators include their focus on intersectional advocacy, peer-led service delivery, and partnerships with local clinics and social service networks to bridge gaps in care access. Award history does not provide sufficient detail to identify specific federal agencies or contract types, so no agency experience can be confirmed from available data. Similarly, while the primary NAICS code 624190 indicates “Other Social Assistance,” this reflects operational activities centered on non-residential community health support, outreach coordination, and preventive health services rather than clinical care delivery. The organization’s market positioning aligns with mission-driven social service providers focused on public health equity, particularly in populations disproportionately impacted by infectious diseases and systemic healthcare disparities. As a Woman-Owned Business certified under the SBA’s 8(a) program, the organization operates as a small, mission-led entity based in Oakland, California, with a localized but impactful presence in Northern California’s public health ecosystem. Their structure emphasizes grassroots leadership and community-based staffing, enabling responsive, hyper-local service delivery. Certification as a Woman-Owned Business underscores their commitment to inclusive economic participation and equitable health access.

Key Performance Metrics

Awards Count

9

All time

Active

1

Currently performing

Completed

8

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
- Unknown NAICS$2.6M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with WOMEN ORGANIZED TO RESPOND TO LIFE THREATENING DISEASES

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for WOMEN ORGANIZED TO RESPOND TO LIFE THREATENING DISEASES

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in WOMEN ORGANIZED TO RESPOND TO LIFE THREATENING DISEASES's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development of commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants must be for-profit entities located in the U.S., owned more than 50 percent by U.S. citizens or permanent residents, and employ no more than 500 people. The program accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being NIH-specific options to accelerate development. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, considering commercial potential, technical feasibility, and the quality of the commercialization plan. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines; notably, several institutes, including NIAID and NIAMS, do not accept clinical trials under this NOFO. Applicants must maintain active registrations in SAM, possess a Unique Entity Identifier, and comply with cybersecurity incident reporting requirements, including notifying HHS within 48 hours of a discovery.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the environment for success. While clinical trials are generally optional, they are prohibited for specific components, including all FDA centers and several NIH institutes such as NIAMS and NIDCR. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. All applications must be submitted electronically, with a final expiration date of April 06, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including technical assistance for regulatory and intellectual property strategies, manufacturing scale-up, independent replication of key studies, and clinical trials. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible applicants must be for-profit organizations with no more than 500 employees and maintain active registrations in the System for Award Management and the SBA Company Registry. Project periods are limited to a maximum of three years, with budget ceilings varying by participating Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan and a CRP progress report, while costs for patent or FDA filing fees and separate Technical and Business Assistance funding are strictly prohibited.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details